Table 4.
Patients (n = 15) | |
---|---|
Death | 7 (46.7) |
Life-threatening or severe bleeding | - |
Number of red blood cell transfusions | 8.79 ± 9.6 |
Device-related complications | |
Access-site bleeding | - |
Haemolysis | 4 (26.6) |
Limb ischaemia | 3 (20.0) |
Sepsis | 9 (60.0) |
Acute kidney injury * | 10 (66.7) |
Need for renal replacement therapy | 7 (46.7) |
Escalation therapy | 2 (13.3) |
LVEF at discharge, % | 35.8 ± 17.7 |
In-hospital outcomes are reported as n (%) or mean ± standard deviation as appropriate; LVEF, left ventricular ejection fraction. * Defined as a serum creatinine increase ≥ 0.3 mg/dL from the baseline. Defined as the need for extracorporeal membrane oxygenation, left ventricular assist device implantation or heart transplant.